AP NEWS

Global Early Toxicology Testing Market 2018-2022 - ResearchAndMarkets.com

October 2, 2018

DUBLIN--(BUSINESS WIRE)--Oct 2, 2018--The “Global Early Toxicology Testing Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The Global Early Toxicology Testing Market to grow at a CAGR of 7.84% during the period 2018-2022.

Global Early Toxicology Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver influencing this market is the high rejection of drugs. Toxicity in drugs is one of the major reasons behind the drugs rejection in the last development phase or for drugs withdrawal from the market which is fueling the demand for early toxicology testing.

One trend affecting this market is the increased advances in toxicology. The field of toxicology is characterized by advanced understanding of human functions and diseases at a molecular level while mitigating human and animal studies.

Further, the report states that one challenge affecting this market is the limitations of preclinical studies. With the increasing preclinical study limitations, the technicians and professionals find it challenging to adopt early toxicology testing.

Key vendors:

Bio-Rad Laboratories Charles River Eurofins Scientific Merck & Co Thermo Fisher Scientific

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 05: MARKET SIZING

Market definition Market sizing 2017 Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

Segmentation by end-user Comparison by end-user Pharmaceutical and biotechnology Academic institutions and research laboratories Others - Market size and forecast 2017-2022 Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

Geographical segmentation Regional comparison Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

Advances in toxicology Increasing demand for cosmetics Increasing drug discovery

PART 13: VENDOR LANDSCAPE

Overview Landscape disruption

PART 14: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/6xx39j/global_early?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181002005937/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/02/2018 01:42 PM/DISC: 10/02/2018 01:42 PM

http://www.businesswire.com/news/home/20181002005937/en

AP RADIO
Update hourly